Potent and selective non-cysteine-containing inhibitors of protein farnesyltransferase

被引:45
作者
Augeri, DJ
O'Connor, SJ
Janowick, D
Szczepankiewicz, B
Sullivan, G
Larsen, J
Kalvin, D
Cohen, J
Devine, E
Zhang, HC
Cherian, S
Saeed, B
Ng, SC
Rosenberg, S
机构
[1] Abbott Labs, Dept Canc Res, Abbott Pk, IL 60064 USA
[2] Abbott Labs, Dept Combinatorial Chem, Abbott Pk, IL 60064 USA
关键词
D O I
10.1021/jm980298s
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Potent and selective non-thiol-containing inhibitors of protein farnesyltransferase are described. FTI-276 (1) was transformed into pyridyl ether analogue 19. The potency of pyridyl ether 19 was improved by modification of the biphenyl core to that of an o-tolyl substituted biphenyl core to give 29. In addition to 0.4 nM in vitro potency, 29 displayed 350 nM potency in whole cells as the parent carboxylic acid. The o-tolyl biphenyl core dramatically and unexpectedly enhanced the potency of other compounds as exemplified by 46, 47, 48, and 49.
引用
收藏
页码:4288 / 4300
页数:13
相关论文
共 31 条
[1]   RAS GENES [J].
BARBACID, M .
ANNUAL REVIEW OF BIOCHEMISTRY, 1987, 56 :779-827
[2]  
BOS JL, 1989, CANCER RES, V49, P4682
[3]   Novel conformationally extended naphthalene-based inhibitors of farnesyltransferase [J].
Burns, CJ ;
Guitton, JD ;
Baudoin, B ;
Lelievre, Y ;
Duchesne, M ;
Parker, F ;
Fromage, N ;
Commercon, A .
JOURNAL OF MEDICINAL CHEMISTRY, 1997, 40 (12) :1763-1767
[4]  
CASEY PJ, 1989, P NATL ACAD SCI USA, V86, P8223
[5]   Farnesyltransferase inhibitors and cancer treatment: targeting simply Ras? [J].
Cox, AD ;
Der, CJ .
BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER, 1997, 1333 (01) :F51-F71
[6]  
Cox Adrienne D., 1992, Current Opinion in Cell Biology, V4, P1008, DOI 10.1016/0955-0674(92)90133-W
[7]   PSEUDODIPEPTIDE INHIBITORS OF PROTEIN FARNESYLTRANSFERASE [J].
DESOLMS, SJ ;
DEANA, AA ;
GIULIANI, EA ;
GRAHAM, SL ;
KOHL, NE ;
MOSSER, SD ;
OLIFF, AI ;
POMPLIANO, DL ;
RANDS, E ;
SCHOLZ, TH ;
WIGGINS, JM ;
GIBBS, JB ;
SMITH, RL .
JOURNAL OF MEDICINAL CHEMISTRY, 1995, 38 (20) :3967-3971
[8]   The potential of farnesyltransferase inhibitors as cancer chemotherapeutics [J].
Gibbs, JB ;
Oliff, A .
ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, 1997, 37 :143-166
[9]   FARNESYLTRANSFERASE INHIBITORS - RAS RESEARCH YIELDS A POTENTIAL CANCER THERAPEUTIC [J].
GIBBS, JB ;
OLIFF, A ;
KOHL, NE .
CELL, 1994, 77 (02) :175-178
[10]   PSEUDOPEPTIDE INHIBITORS OF RAS FARNESYL-PROTEIN TRANSFERASE [J].
GRAHAM, SL ;
DESOLMS, SJ ;
GIULIANI, EA ;
KOHL, NE ;
MOSSER, SD ;
OLIFF, AI ;
POMPLIANO, DL ;
RANDS, E ;
BRESLIN, MJ ;
DEANA, AA ;
GARSKY, VM ;
SCHOLZ, TH ;
GIBBS, JB ;
SMITH, RL .
JOURNAL OF MEDICINAL CHEMISTRY, 1994, 37 (06) :725-732